The Limited Times

Now you can see non-English news...

Curevac - what can now become of the German vaccine hope? (Podcast)


About a year ago, Curevac was considered a beacon of hope in the fight against Corona. This podcast informs why the German biotech company failed with its plan despite the best conditions and what the future prospects are.

The German biotech company Curevac was one of the hopes for the world about a year ago: Like Biontech and Moderna, it wanted to quickly develop a vaccine against the coronavirus.

At the beginning of summer 2021 one has to state: While Biontech has matured into a world star, Curevac stands for a botched opportunity of the century.

What are the reasons for this and what can be learned from it? What role does the German billionaire, entrepreneur and patron Dietmar Hopp play in this? And why could the Curevac case still help the German biotech industry? The mm editors Dietmar Palan, Martin Noé and Sven Clausen discuss this in this podcast.

Source: spiegel

All news articles on 2021-06-22

You may like

Tech/Game 2021-06-22T09:37:45.820Z
News/Politics 2021-05-01T11:39:37.468Z
News/Politics 2021-05-02T02:53:20.108Z

Trends 24h


© Communities 2019 - Privacy